Management of NSAID-Induced Upper GI Bleeding
This patient must be admitted to the hospital and undergo urgent upper endoscopy (Option C). This presentation represents a life-threatening upper gastrointestinal hemorrhage requiring immediate inpatient management, hemodynamic stabilization, and diagnostic endoscopy.
Clinical Presentation Indicating Severe GI Bleeding
This patient demonstrates clear evidence of significant upper GI bleeding:
- Coffee ground vomitus indicates active or recent upper GI bleeding with gastric acid exposure to blood
- Melena (black tarry stools) for 2 days suggests ongoing hemorrhage with substantial blood loss
- Hemodynamic instability: Tachycardia (HR 118 bpm) with borderline blood pressure (100/80 mmHg) indicates compensated shock from volume depletion
- Pallor suggests significant anemia from blood loss
- Epigastric tenderness localizes the bleeding source to the upper GI tract
The combination of NSAID use (naproxen) and these findings strongly suggests NSAID-induced peptic ulcer disease with active bleeding 1.
Why Admission and Endoscopy Are Mandatory
Outpatient management (Options A and B) is contraindicated and potentially fatal in this clinical scenario:
- The patient has signs of hemodynamic compromise requiring IV fluid resuscitation and possible blood transfusion
- Active upper GI bleeding requires risk stratification through endoscopy to determine bleeding source, severity, and need for therapeutic intervention
- Endoscopic therapy (cauterization, clipping, injection) may be necessary to achieve hemostasis
- Mortality risk increases significantly without prompt intervention in patients with ongoing bleeding 1
Role of IV Proton Pump Inhibitor Therapy
While Option D (admit and give IV omeprazole) is partially correct, it is incomplete as the primary answer:
- IV PPI therapy should be initiated immediately upon presentation, even before endoscopy, as omeprazole is effective in healing NSAID-induced ulcers 1
- PPIs reduce rebleeding rates and may decrease the need for surgical intervention
- However, PPI therapy alone without endoscopy is inadequate management for a patient with active bleeding and hemodynamic changes
The complete management requires BOTH admission with endoscopy AND IV PPI therapy, making Option C the most accurate single best answer, with the understanding that IV omeprazole should be started concurrently 2, 3.
Immediate Management Algorithm
Upon presentation, the following steps should occur simultaneously:
Hemodynamic stabilization:
- Establish large-bore IV access (two lines)
- Initiate crystalloid resuscitation
- Type and crossmatch blood for potential transfusion
- Monitor vital signs continuously
Pharmacologic therapy:
Diagnostic evaluation:
- Complete blood count to assess degree of anemia
- Coagulation studies
- Urgent upper endoscopy within 24 hours (ideally within 12 hours for high-risk patients with hemodynamic instability)
Common Pitfalls to Avoid
- Never discharge a patient with melena and hemodynamic changes, even if they appear stable at the moment—compensated shock can rapidly deteriorate 1
- Do not delay endoscopy for "elective" scheduling—this is an urgent indication requiring inpatient evaluation
- Oral PPI therapy is insufficient for active bleeding; IV administration achieves more rapid and sustained acid suppression 2, 3
- Do not restart NSAIDs after this episode; transition to acetaminophen (up to 4g daily) for osteoarthritis pain management 1
Post-Stabilization Considerations
After endoscopic evaluation and hemostasis:
- Continue high-dose PPI therapy (omeprazole 40 mg twice daily) for at least 8 weeks to allow ulcer healing 2, 3
- Test for Helicobacter pylori and eradicate if present, as this reduces rebleeding risk 2
- Permanently discontinue naproxen and substitute with acetaminophen as first-line therapy for osteoarthritis 1
- If NSAIDs are absolutely necessary in the future (which should be avoided given this history), use the lowest-risk agent (ibuprofen 1.2g daily) with continuous PPI prophylaxis 1
- This patient now has a documented history of NSAID-induced GI bleeding, placing them in the highest risk category for future complications 1, 2, 3